C+1A mutation
Supplementary Table S1 | Primers used for construct cloning in this study.
Name Sequence
SalI-mGFP5 5'-ACGCGTCGACCAAGGAGATATAACAATGAGTAAAGGAG AAGAACT-3'
Supplementary Methods
Gel electrophoresis and western blot analysis. Protein extracts were denatured in SDS-PAGE sample buffer (50 mM Tris-HCl pH 6.8, 2% sodium dodecyl sulfate, 10% glycerol, 0.01% bromophenol blue and 25 mM 2-mercaptoethanol) by heating at 95°C for 5 min. SDS-PAGE and western blot of the denatured samples were carried out as described previously. Anti-GFP rabbit serum (Invitrogen, Grand Island, NY), mouse anti-His tag (Lamda Biotech, St. Louis, MO) and rabbit anti-Strep tag II (Genscript, Piscataway, NJ) were used to detect processed proteins. Goat anti-rabbit or goat anti-mouse conjugated with alkaline phosphatase was used as secondary antibody (Southern Biotech, Birmingham, AL).
CAT assay. Extracts of E. coli expressing GFP 172 -DI-CAT Strep were diluted in a reaction mixture containing 100 mM Tris buffer (pH 7.8), 8 mM of 5,5'-Dithio-bis (2-Nitrobenzoic Acid) (DTNB), and 16 mM of Acetyl Coenzyme A. After equilibration, the reaction was initiated by adding 0.005% of chloramphenicol. The enzyme activity was calculated based on the increase of A 412 over 5 min at room temperature.
